Osteonecrosis of the jaw

Bogna Drozdzowska

doi:10.5603/ep.25314

Vol 62, No 1 (2011)

Review paper

Submitted: 2013-02-15

Published online: 2011-03-01

View PDF

Download PDF file

Get Citation

Osteonecrosis of the jaw

Bogna Drozdzowska

DOI: 10.5603/ep.25314

Endokrynol Pol 2011;62(1):88-92.

Vol 62, No 1 (2011)

Review Article

Submitted: 2013-02-15

Published online: 2011-03-01

Abstract

This review looks at osteonecrosis in the stomatognathic system (mainly the jaws). Osteonecrosis of the jaw (ONJ) is a rare but serious clinical condition. It affects patients treated with bisphosphonates, and also with denosumab, mainly in oncological doses. In osteoporosis, it is a problem of relatively small significance. Article presents a thorough review of this phenomenon, including its definition, pathogenesis, risk factors, prevention and treatment methods, and its incidence rate. (Pol J Endocrinol 2011; 62 (1): 88-92)

Abstract

Full Text:

View PDF

Download PDF file

Get Citation

Keywords

osteonecrosis of the jaw; bisphosphonates; denosumab

About this article

Title

Osteonecrosis of the jaw

Journal

Endokrynologia Polska

Issue

Vol 62, No 1 (2011)

Article type

Review paper

Pages

88-92

Published online

2011-03-01

Page views

501

Article views/downloads

1304

DOI

10.5603/ep.25314

Bibliographic record

Endokrynol Pol 2011;62(1):88-92.

Keywords

osteonecrosis of the jaw
bisphosphonates
denosumab

Authors

Bogna Drozdzowska